IMP
Process View
positive regulation of cysteine type endopeptidase activity involved in apoptotic process
Any process that activates or increases the activity of a cysteine-type endopeptidase involved in the apoptotic process.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "positive regulation of cysteine type endopeptidase activity involved in apoptotic process"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| CASP8 | caspase 8, apoptosis-related cysteine peptidase | 1.000 | Mouse | |
| BCL2 | B-cell CLL/lymphoma 2 | 1.000 | Human | |
| MDM2 | Mdm2 p53 binding protein homolog (mouse) | 1.000 | ||
| CFLAR | CASP8 and FADD-like apoptosis regulator | 0.998 | ||
| CASP10 | caspase 10, apoptosis-related cysteine peptidase | 0.998 | ||
| CREBBP | CREB binding protein | 0.997 | ||
| CASP1 | caspase 1, apoptosis-related cysteine peptidase (interleukin 1, beta, convertase) | 0.996 | Fly | |
| FAS | Fas (TNF receptor superfamily, member 6) | 0.996 | Rat | |
| CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | 0.995 | Human | |
| TP53 | tumor protein p53 | 0.994 | Zebrafish Fly | |
| FADD | Fas (TNFRSF6)-associated via death domain | 0.994 | ||
| S100B | S100 calcium binding protein B | 0.990 | Human | |
| BCL2L1 | BCL2-like 1 | 0.990 | Human | |
| RIPK1 | receptor (TNFRSF)-interacting serine-threonine kinase 1 | 0.989 | ||
| YWHAZ | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide | 0.986 | ||
| TNFRSF10A | tumor necrosis factor receptor superfamily, member 10a | 0.982 | ||
| BID | BH3 interacting domain death agonist | 0.981 | Mouse | |
| TNFRSF10B | tumor necrosis factor receptor superfamily, member 10b | 0.978 | Zebrafish | |
| XIAP | X-linked inhibitor of apoptosis | 0.974 | ||
| SMAD1 | SMAD family member 1 | 0.972 | Human | |
| HIF1A | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 0.971 | ||
| CASP9 | caspase 9, apoptosis-related cysteine peptidase | 0.969 | Mouse | |
| IKBKG | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma | 0.963 | ||
| RIPK2 | receptor-interacting serine-threonine kinase 2 | 0.960 | ||
| BAX | BCL2-associated X protein | 0.960 | ||
| CASP2 | caspase 2, apoptosis-related cysteine peptidase | 0.951 | Fly | |
| S100A6 | S100 calcium binding protein A6 | 0.944 | Human | |
| CASP3 | caspase 3, apoptosis-related cysteine peptidase | 0.937 | ||
| POU5F1 | POU class 5 homeobox 1 | 0.934 | ||
| BCL2L11 | BCL2-like 11 (apoptosis facilitator) | 0.925 | ||
| MCL1 | myeloid cell leukemia sequence 1 (BCL2-related) | 0.923 | Human | |
| HSP90AA1 | heat shock protein 90kDa alpha (cytosolic), class A member 1 | 0.906 | ||
| TNFRSF1A | tumor necrosis factor receptor superfamily, member 1A | 0.904 | ||
| UBE2I | ubiquitin-conjugating enzyme E2I (UBC9 homolog, yeast) | 0.903 | ||
| CDKN2A | cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | 0.902 | ||
| SUMO1 | SMT3 suppressor of mif two 3 homolog 1 (S. cerevisiae) | 0.893 | ||
| HIPK2 | homeodomain interacting protein kinase 2 | 0.861 | ||
| SMAD3 | SMAD family member 3 | 0.837 | ||
| SMAD4 | SMAD family member 4 | 0.829 | Human | |
| NLRC4 | NLR family, CARD domain containing 4 | 0.821 | ||
| MAPK8 | mitogen-activated protein kinase 8 | 0.811 | ||
| TRAF2 | TNF receptor-associated factor 2 | 0.806 | ||
| SRC | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) | 0.802 | Human | |
| RB1 | retinoblastoma 1 | 0.790 | ||
| EIF3L | eukaryotic translation initiation factor 3, subunit L | 0.781 | ||
| TRAF1 | TNF receptor-associated factor 1 | 0.780 | ||
| BIRC3 | baculoviral IAP repeat containing 3 | 0.770 | ||
| APAF1 | apoptotic peptidase activating factor 1 | 0.764 | ||
| FYN | FYN oncogene related to SRC, FGR, YES | 0.757 | Human | |
| S100A1 | S100 calcium binding protein A1 | 0.755 | Human | |
| RXRA | retinoid X receptor, alpha | 0.729 | ||
| SQSTM1 | sequestosome 1 | 0.718 | ||
| NR4A1 | nuclear receptor subfamily 4, group A, member 1 | 0.717 | ||
| S100A4 | S100 calcium binding protein A4 | 0.714 | Human | |
| TNFSF10 | tumor necrosis factor (ligand) superfamily, member 10 | 0.694 | ||
| TNFRSF6B | tumor necrosis factor receptor superfamily, member 6b, decoy | 0.683 | ||
| BMP2 | bone morphogenetic protein 2 | 0.682 | ||
| CDK2 | cyclin-dependent kinase 2 | 0.668 | ||
| PYCARD | PYD and CARD domain containing | 0.665 | ||
| CYR61 | cysteine-rich, angiogenic inducer, 61 | 0.653 | Mouse | |
| VDAC2 | voltage-dependent anion channel 2 | 0.645 | ||
| AR | androgen receptor | 0.636 | ||
| DAXX | death-domain associated protein | 0.636 | ||
| PPP2CA | protein phosphatase 2, catalytic subunit, alpha isozyme | 0.629 | Rat | |
| SMAD7 | SMAD family member 7 | 0.621 | Human | |
| TGFB1 | transforming growth factor, beta 1 | 0.615 | ||
| SUMO2 | SMT3 suppressor of mif two 3 homolog 2 (S. cerevisiae) | 0.608 | ||
| CARD11 | caspase recruitment domain family, member 11 | 0.606 | ||
| ESR1 | estrogen receptor 1 | 0.605 | ||
| HMGB2 | high mobility group box 2 | 0.584 | Human | |
| PAX3 | paired box 3 | 0.583 | ||
| SKIL | SKI-like oncogene | 0.582 | ||
| BIRC2 | baculoviral IAP repeat containing 2 | 0.574 | ||
| SP1 | Sp1 transcription factor | 0.572 | ||
| NCL | nucleolin | 0.569 | ||
| SUMO3 | SMT3 suppressor of mif two 3 homolog 3 (S. cerevisiae) | 0.568 | ||
| HMGB1 | high mobility group box 1 | 0.563 | ||
| FKBP1A | FK506 binding protein 1A, 12kDa | 0.562 | ||
| CRADD | CASP2 and RIPK1 domain containing adaptor with death domain | 0.560 | Mouse | |
| EPAS1 | endothelial PAS domain protein 1 | 0.543 | ||
| SMN1 | survival of motor neuron 1, telomeric | 0.538 | ||
| BCAP31 | B-cell receptor-associated protein 31 | 0.532 | ||
| HCK | hemopoietic cell kinase | 0.522 | Human | |
| S100A14 | S100 calcium binding protein A14 | 0.513 | ||
| POU3F2 | POU class 3 homeobox 2 | 0.509 | ||
| SMAD2 | SMAD family member 2 | 0.506 | Human | |
| PPARGC1A | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha | 0.502 | ||
| PIAS4 | protein inhibitor of activated STAT, 4 | 0.499 | ||
| FASLG | Fas ligand (TNF superfamily, member 6) | 0.493 | ||
| TNFRSF1B | tumor necrosis factor receptor superfamily, member 1B | 0.489 | ||
| HNF4A | hepatocyte nuclear factor 4, alpha | 0.485 | ||
| BAK1 | BCL2-antagonist/killer 1 | 0.466 | Human | |
| TRADD | TNFRSF1A-associated via death domain | 0.463 | ||
| VDAC1 | voltage-dependent anion channel 1 | 0.450 | ||
| NCOR2 | nuclear receptor corepressor 2 | 0.445 | ||
| IKBKB | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta | 0.420 | ||
| ENG | endoglin | 0.417 | ||
| CAV1 | caveolin 1, caveolae protein, 22kDa | 0.388 | ||
| PPP1CC | protein phosphatase 1, catalytic subunit, gamma isozyme | 0.385 | ||
| SYK | spleen tyrosine kinase | 0.381 | ||
| BMPR1B | bone morphogenetic protein receptor, type IB | 0.374 | Human | |
| BMPR2 | bone morphogenetic protein receptor, type II (serine/threonine kinase) | 0.365 | Human | |
| COL4A2 | collagen, type IV, alpha 2 | 0.363 | Human | |
| PML | promyelocytic leukemia | 0.359 | Mouse | |
| AREG | amphiregulin | 0.354 | ||
| NAP1L1 | nucleosome assembly protein 1-like 1 | 0.348 | ||
| PMAIP1 | phorbol-12-myristate-13-acetate-induced protein 1 | 0.327 | ||
| COL4A4 | collagen, type IV, alpha 4 | 0.326 | Human | |
| COL4A3 | collagen, type IV, alpha 3 (Goodpasture antigen) | 0.320 | ||
| JUN | jun proto-oncogene | 0.311 | ||
| SPRR2A | small proline-rich protein 2A | 0.311 | ||
| COL4A1 | collagen, type IV, alpha 1 | 0.307 | Human | |
| NUCKS1 | nuclear casein kinase and cyclin-dependent kinase substrate 1 | 0.294 | ||
| PELP1 | proline, glutamate and leucine rich protein 1 | 0.294 | ||
| CTGF | connective tissue growth factor | 0.294 | Rat | |
| EIF3E | eukaryotic translation initiation factor 3, subunit E | 0.289 | ||
| VHL | von Hippel-Lindau tumor suppressor | 0.288 | ||
| EIF4E | eukaryotic translation initiation factor 4E | 0.282 | ||
| PIAS1 | protein inhibitor of activated STAT, 1 | 0.276 | ||
| SMAD9 | SMAD family member 9 | 0.270 | Human | |
| RARA | retinoic acid receptor, alpha | 0.260 | ||
| C9orf89 | chromosome 9 open reading frame 89 | 0.250 | ||
| MAPK1 | mitogen-activated protein kinase 1 | 0.235 | ||
| PSIP1 | PC4 and SFRS1 interacting protein 1 | 0.228 | ||
| MAP2K4 | mitogen-activated protein kinase kinase 4 | 0.224 | ||
| BBS10 | Bardet-Biedl syndrome 10 | 0.223 | ||
| NCK1 | NCK adaptor protein 1 | 0.222 | ||
| BMPR1A | bone morphogenetic protein receptor, type IA | 0.220 | Human | |
| ASB2 | ankyrin repeat and SOCS box containing 2 | 0.220 | ||
| SET | SET nuclear oncogene | 0.215 | ||
| HSP90AB1 | heat shock protein 90kDa alpha (cytosolic), class B member 1 | 0.207 | ||
| NCOR1 | nuclear receptor corepressor 1 | 0.201 | ||
| WFIKKN2 | WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2 | 0.198 | ||
| ATP5B | ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide | 0.197 | ||
| HSP90B1 | heat shock protein 90kDa beta (Grp94), member 1 | 0.193 | ||
| SMAD6 | SMAD family member 6 | 0.191 | Human | |
| C4orf14 | chromosome 4 open reading frame 14 | 0.189 | ||
| STUB1 | STIP1 homology and U-box containing protein 1, E3 ubiquitin protein ligase | 0.188 | ||
| GDF5 | growth differentiation factor 5 | 0.185 | Human | |
| WWP2 | WW domain containing E3 ubiquitin protein ligase 2 | 0.182 | ||
| RAF1 | v-raf-1 murine leukemia viral oncogene homolog 1 | 0.181 | ||
| RAC1 | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) | 0.177 | ||
| TANK | TRAF family member-associated NFKB activator | 0.176 | ||
| BIK | BCL2-interacting killer (apoptosis-inducing) | 0.176 | ||
| LRDD | leucine-rich repeats and death domain containing | 0.174 | Mouse | |
| MED25 | mediator complex subunit 25 | 0.168 | ||
| SMARCC1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1 | 0.168 | ||
| CDK6 | cyclin-dependent kinase 6 | 0.166 | ||
| EGLN3 | egl nine homolog 3 (C. elegans) | 0.165 | ||
| HUWE1 | HECT, UBA and WWE domain containing 1 | 0.165 | ||
| S100A11 | S100 calcium binding protein A11 | 0.163 | Human | |
| THBS1 | thrombospondin 1 | 0.161 | ||
| MYC | v-myc myelocytomatosis viral oncogene homolog (avian) | 0.161 | ||
| EGFR | epidermal growth factor receptor | 0.158 | ||
| WDR5 | WD repeat domain 5 | 0.158 | ||
| FH | fumarate hydratase | 0.151 | ||
| MDM4 | Mdm4 p53 binding protein homolog (mouse) | 0.150 | ||
| MAPK6 | mitogen-activated protein kinase 6 | 0.149 | ||
| MYB | v-myb myeloblastosis viral oncogene homolog (avian) | 0.149 | ||
| CCND1 | cyclin D1 | 0.148 | ||
| COL4A6 | collagen, type IV, alpha 6 | 0.144 | Human | |
| GRB2 | growth factor receptor-bound protein 2 | 0.141 | ||
| MALT1 | mucosa associated lymphoid tissue lymphoma translocation gene 1 | 0.140 | ||
| EGLN1 | egl nine homolog 1 (C. elegans) | 0.139 | Human | |
| PSTPIP1 | proline-serine-threonine phosphatase interacting protein 1 | 0.138 | ||
| ITGA5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 0.134 | ||
| IBTK | inhibitor of Bruton agammaglobulinemia tyrosine kinase | 0.133 | ||
| NOG | noggin | 0.130 | ||
| TYMP | thymidine phosphorylase | 0.130 | ||
| SSX4 | synovial sarcoma, X breakpoint 4 | 0.128 | ||
| CASP4 | caspase 4, apoptosis-related cysteine peptidase | 0.127 | Fly | |
| SOX2 | SRY (sex determining region Y)-box 2 | 0.127 | Human | |
| S100A2 | S100 calcium binding protein A2 | 0.126 | Human | |
| CCNE1 | cyclin E1 | 0.125 | ||
| TGFBR1 | transforming growth factor, beta receptor 1 | 0.122 | Human | |
| PTGES3 | prostaglandin E synthase 3 (cytosolic) | 0.122 | ||
| CPE | carboxypeptidase E | 0.121 | ||
| ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.121 | ||
| CHEK2 | CHK2 checkpoint homolog (S. pombe) | 0.121 | Fly | |
| CYLD | cylindromatosis (turban tumor syndrome) | 0.120 | ||
| BAG1 | BCL2-associated athanogene | 0.119 | ||
| GSK3B | glycogen synthase kinase 3 beta | 0.118 | ||
| RAD21 | RAD21 homolog (S. pombe) | 0.117 | ||
| SKP2 | S-phase kinase-associated protein 2 (p45) | 0.116 | ||
| MDH2 | malate dehydrogenase 2, NAD (mitochondrial) | 0.114 | Fly | |
| FSTL1 | follistatin-like 1 | 0.114 | ||
| NRP1 | neuropilin 1 | 0.113 | ||
| XPO1 | exportin 1 (CRM1 homolog, yeast) | 0.113 | ||
| COL4A5 | collagen, type IV, alpha 5 | 0.112 | Human | |
| FAM46A | family with sequence similarity 46, member A | 0.111 | ||
| LYN | v-yes-1 Yamaguchi sarcoma viral related oncogene homolog | 0.111 | ||
| YY1 | YY1 transcription factor | 0.110 | ||
| NOD1 | nucleotide-binding oligomerization domain containing 1 | 0.109 | ||
| NAF1 | nuclear assembly factor 1 homolog (S. cerevisiae) | 0.108 | ||
| EGR1 | early growth response 1 | 0.107 | ||
| TBK1 | TANK-binding kinase 1 | 0.107 | Fly | |
| PTMA | prothymosin, alpha | 0.105 | ||
| TGFB3 | transforming growth factor, beta 3 | 0.105 | ||
| PYDC2 | pyrin domain containing 2 | 0.104 | ||
| KAT2B | K(lysine) acetyltransferase 2B | 0.104 | ||
| RASA1 | RAS p21 protein activator (GTPase activating protein) 1 | 0.103 | ||
| FOS | FBJ murine osteosarcoma viral oncogene homolog | 0.102 | ||
| STAT3 | signal transducer and activator of transcription 3 (acute-phase response factor) | 0.100 | ||
| LCK | lymphocyte-specific protein tyrosine kinase | 0.099 | ||
| CAPG | capping protein (actin filament), gelsolin-like | 0.098 | ||
| SPDEF | SAM pointed domain containing ets transcription factor | 0.096 | ||
| ARRB2 | arrestin, beta 2 | 0.096 | ||
| RPS25 | ribosomal protein S25 | 0.096 | ||
| AKT1 | v-akt murine thymoma viral oncogene homolog 1 | 0.096 | ||
| CASP8AP2 | caspase 8 associated protein 2 | 0.095 | ||
| LGALS3 | lectin, galactoside-binding, soluble, 3 | 0.093 | ||
| ZMYND11 | zinc finger, MYND-type containing 11 | 0.093 | ||
| SH3KBP1 | SH3-domain kinase binding protein 1 | 0.091 | ||
| TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 | 0.091 | ||
| HR | hairless homolog (mouse) | 0.091 | ||
| EDF1 | endothelial differentiation-related factor 1 | 0.090 | ||
| DUSP1 | dual specificity phosphatase 1 | 0.088 | ||
| SLC25A5 | solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 5 | 0.087 | ||
| TMX2 | thioredoxin-related transmembrane protein 2 | 0.086 | ||
| STRAP | serine/threonine kinase receptor associated protein | 0.086 | ||
| SOCS1 | suppressor of cytokine signaling 1 | 0.085 | ||
| EP300 | E1A binding protein p300 | 0.084 | ||
| BLNK | B-cell linker | 0.083 | ||
| HPRT1 | hypoxanthine phosphoribosyltransferase 1 | 0.083 | ||
| DAB2IP | DAB2 interacting protein | 0.083 | ||
| AP2A1 | adaptor-related protein complex 2, alpha 1 subunit | 0.083 | ||
| CDC37 | cell division cycle 37 homolog (S. cerevisiae) | 0.082 | ||
| SNCAIP | synuclein, alpha interacting protein | 0.081 | ||
| TRAF3 | TNF receptor-associated factor 3 | 0.080 | ||
| ELF4 | E74-like factor 4 (ets domain transcription factor) | 0.080 | ||
| STAT1 | signal transducer and activator of transcription 1, 91kDa | 0.079 | Mouse | |
| MLL | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila) | 0.079 | ||
| MAP3K7 | mitogen-activated protein kinase kinase kinase 7 | 0.078 | ||
| HDAC1 | histone deacetylase 1 | 0.077 | ||
| TXN | thioredoxin | 0.077 | ||
| FOXD3 | forkhead box D3 | 0.075 | Human | |
| PPP2R5C | protein phosphatase 2, regulatory subunit B', gamma | 0.075 | ||
| IFNGR1 | interferon gamma receptor 1 | 0.075 | ||
| CXXC5 | CXXC finger protein 5 | 0.074 | ||
| ITK | IL2-inducible T-cell kinase | 0.074 | ||
| RBCK1 | RanBP-type and C3HC4-type zinc finger containing 1 | 0.074 | ||
| PLP2 | proteolipid protein 2 (colonic epithelium-enriched) | 0.073 | ||
| RDH11 | retinol dehydrogenase 11 (all-trans/9-cis/11-cis) | 0.073 | ||
| PPP1CA | protein phosphatase 1, catalytic subunit, alpha isozyme | 0.072 | ||
| GADD45A | growth arrest and DNA-damage-inducible, alpha | 0.071 | ||
| MTOR | mechanistic target of rapamycin (serine/threonine kinase) | 0.071 | ||
| S100P | S100 calcium binding protein P | 0.071 | Human | |
| TFCP2 | transcription factor CP2 | 0.071 | ||
| VIM | vimentin | 0.069 | ||
| MEOX2 | mesenchyme homeobox 2 | 0.069 | ||
| IDH3A | isocitrate dehydrogenase 3 (NAD+) alpha | 0.069 | ||
| SOCS3 | suppressor of cytokine signaling 3 | 0.069 | ||
| ANXA1 | annexin A1 | 0.068 | ||
| CLTC | clathrin, heavy chain (Hc) | 0.067 | ||
| FKBP3 | FK506 binding protein 3, 25kDa | 0.066 | ||
| ARNT | aryl hydrocarbon receptor nuclear translocator | 0.066 | ||
| TP53BP2 | tumor protein p53 binding protein, 2 | 0.066 | ||
| HDAC2 | histone deacetylase 2 | 0.065 | ||
| FGR | Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog | 0.065 | Human | |
| CDK5 | cyclin-dependent kinase 5 | 0.064 | ||
| GOT1 | glutamic-oxaloacetic transaminase 1, soluble (aspartate aminotransferase 1) | 0.064 | ||
| CLU | clusterin | 0.064 | ||
| BMP4 | bone morphogenetic protein 4 | 0.064 | ||
| INHBB | inhibin, beta B | 0.064 | ||
| SLC25A11 | solute carrier family 25 (mitochondrial carrier; oxoglutarate carrier), member 11 | 0.062 | ||
| PSME3 | proteasome (prosome, macropain) activator subunit 3 (PA28 gamma; Ki) | 0.062 | ||
| KRT5 | keratin 5 | 0.062 | ||
| BAD | BCL2-associated agonist of cell death | 0.062 | ||
| DIABLO | diablo, IAP-binding mitochondrial protein | 0.062 | ||
| CSTA | cystatin A (stefin A) | 0.061 | ||
| IKBKE | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon | 0.061 | Fly | |
| HSPA9 | heat shock 70kDa protein 9 (mortalin) | 0.061 | ||
| MEFV | Mediterranean fever | 0.060 | ||
| SMURF2 | SMAD specific E3 ubiquitin protein ligase 2 | 0.060 | ||
| HNRNPA3 | heterogeneous nuclear ribonucleoprotein A3 | 0.060 | ||
| MBD1 | methyl-CpG binding domain protein 1 | 0.059 | ||
| WIPF1 | WAS/WASL interacting protein family, member 1 | 0.059 | ||
| WAS | Wiskott-Aldrich syndrome (eczema-thrombocytopenia) | 0.059 | ||
| MAX | MYC associated factor X | 0.059 | ||
| TSPO | translocator protein (18kDa) | 0.059 | ||
| GAS7 | growth arrest-specific 7 | 0.059 | ||
| GORAB | golgin, RAB6-interacting | 0.059 | ||
| VDR | vitamin D (1,25- dihydroxyvitamin D3) receptor | 0.057 | Human | |
| BBC3 | BCL2 binding component 3 | 0.057 | ||
| BNIP3 | BCL2/adenovirus E1B 19kDa interacting protein 3 | 0.057 | ||
| DOCK7 | dedicator of cytokinesis 7 | 0.057 | ||
| FOXF1 | forkhead box F1 | 0.056 | ||
| EIF3H | eukaryotic translation initiation factor 3, subunit H | 0.056 | ||
| ATP5G3 | ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9) | 0.055 | ||
| UBE2D1 | ubiquitin-conjugating enzyme E2D 1 (UBC4/5 homolog, yeast) | 0.055 | ||
| BECN1 | beclin 1, autophagy related | 0.054 | ||
| TRIM27 | tripartite motif containing 27 | 0.054 | ||
| ARRB1 | arrestin, beta 1 | 0.054 | ||
| PIM1 | pim-1 oncogene | 0.054 | ||
| HMGN1 | high mobility group nucleosome binding domain 1 | 0.054 | ||
| CXXC1 | CXXC finger protein 1 | 0.054 | ||
| MARCKSL1 | MARCKS-like 1 | 0.053 | ||
| AGER | advanced glycosylation end product-specific receptor | 0.052 | ||
| APEX1 | APEX nuclease (multifunctional DNA repair enzyme) 1 | 0.052 | ||
| DEK | DEK oncogene | 0.052 | ||
| FZD8 | frizzled homolog 8 (Drosophila) | 0.052 | ||
| MYCN | v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian) | 0.052 | Human | |
| MAVS | mitochondrial antiviral signaling protein | 0.051 | ||
| BTRC | beta-transducin repeat containing | 0.051 | ||
| TGFB2 | transforming growth factor, beta 2 | 0.051 | ||
| TNF | tumor necrosis factor | 0.050 | ||
| SPRY4 | sprouty homolog 4 (Drosophila) | 0.049 | ||
| UQCRFS1 | ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1 | 0.049 | ||
| TNFRSF14 | tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator) | 0.048 | ||
| ELK1 | ELK1, member of ETS oncogene family | 0.048 | ||
| NID2 | nidogen 2 (osteonidogen) | 0.048 | ||
| BCL2A1 | BCL2-related protein A1 | 0.048 | Human | |
| WFIKKN1 | WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 1 | 0.048 | ||
| GNL3L | guanine nucleotide binding protein-like 3 (nucleolar)-like | 0.048 | ||
| H2AFV | H2A histone family, member V | 0.048 | ||
| EIF3A | eukaryotic translation initiation factor 3, subunit A | 0.048 | ||
| ST8SIA2 | ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2 | 0.047 | ||
| PRKG1 | protein kinase, cGMP-dependent, type I | 0.047 | ||
| LMNA | lamin A/C | 0.047 | ||
| FHL2 | four and a half LIM domains 2 | 0.047 | ||
| RUNX1 | runt-related transcription factor 1 | 0.047 | ||
| CCND3 | cyclin D3 | 0.047 | ||
| ZFYVE1 | zinc finger, FYVE domain containing 1 | 0.047 | ||
| TUBA1A | tubulin, alpha 1a | 0.046 | ||
| PRDX5 | peroxiredoxin 5 | 0.046 | ||
| CBX3 | chromobox homolog 3 | 0.045 | ||
| BCL2L2 | BCL2-like 2 | 0.045 | ||
| MTA1 | metastasis associated 1 | 0.045 | ||
| LGALS3BP | lectin, galactoside-binding, soluble, 3 binding protein | 0.045 | ||
| ID1 | inhibitor of DNA binding 1, dominant negative helix-loop-helix protein | 0.045 | ||
| COL16A1 | collagen, type XVI, alpha 1 | 0.045 | ||
| IGFBP7 | insulin-like growth factor binding protein 7 | 0.045 | ||
| PACSIN1 | protein kinase C and casein kinase substrate in neurons 1 | 0.044 | ||
| CCKBR | cholecystokinin B receptor | 0.044 | ||
| ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.044 | ||
| NID1 | nidogen 1 | 0.044 | ||
| RPL11 | ribosomal protein L11 | 0.043 | ||
| RNR2 | l-rRNA | 0.043 | ||
| CASP7 | caspase 7, apoptosis-related cysteine peptidase | 0.043 | ||
| GADD45B | growth arrest and DNA-damage-inducible, beta | 0.043 | ||
| FANCD2 | Fanconi anemia, complementation group D2 | 0.042 | ||
| NMI | N-myc (and STAT) interactor | 0.042 | ||
| FGF8 | fibroblast growth factor 8 (androgen-induced) | 0.042 | ||
| CLTCL1 | clathrin, heavy chain-like 1 | 0.042 | ||
| RPS4Y1 | ribosomal protein S4, Y-linked 1 | 0.042 | ||
| LMO4 | LIM domain only 4 | 0.042 | ||
| SLC10A2 | solute carrier family 10 (sodium/bile acid cotransporter family), member 2 | 0.042 | ||
| PPARA | peroxisome proliferator-activated receptor alpha | 0.042 | Human | |
| EIF3F | eukaryotic translation initiation factor 3, subunit F | 0.042 | ||
| JAK3 | Janus kinase 3 | 0.042 | ||
| FEM1B | fem-1 homolog b (C. elegans) | 0.042 | ||
| LAMC1 | laminin, gamma 1 (formerly LAMB2) | 0.041 | ||
| MYH9 | myosin, heavy chain 9, non-muscle | 0.041 | ||
| TAL1 | T-cell acute lymphocytic leukemia 1 | 0.041 | ||
| RBBP5 | retinoblastoma binding protein 5 | 0.041 | ||
| HSPA8 | heat shock 70kDa protein 8 | 0.040 | ||
| SLC6A4 | solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 | 0.040 | ||
| TMSB10 | thymosin beta 10 | 0.040 | ||
| UHRF2 | ubiquitin-like with PHD and ring finger domains 2 | 0.040 | ||
| HOXB13 | homeobox B13 | 0.040 | ||
| PIAS2 | protein inhibitor of activated STAT, 2 | 0.040 | ||
| KLF4 | Kruppel-like factor 4 (gut) | 0.039 | ||
| SERPINB1 | serpin peptidase inhibitor, clade B (ovalbumin), member 1 | 0.039 | ||
| INSR | insulin receptor | 0.039 | ||
| HES1 | hairy and enhancer of split 1, (Drosophila) | 0.039 | ||
| CDK4 | cyclin-dependent kinase 4 | 0.039 | ||
| NOD2 | nucleotide-binding oligomerization domain containing 2 | 0.039 | Human | |
| ANXA4 | annexin A4 | 0.039 | ||
| IER3 | immediate early response 3 | 0.039 | ||
| RNF144B | ring finger protein 144B | 0.039 | ||
| CSNK1E | casein kinase 1, epsilon | 0.039 | ||
| EIF1AY | eukaryotic translation initiation factor 1A, Y-linked | 0.038 | ||
| NPC2 | Niemann-Pick disease, type C2 | 0.038 | ||
| PRMT6 | protein arginine methyltransferase 6 | 0.038 | ||
| SNAI1 | snail homolog 1 (Drosophila) | 0.037 | ||
| ACAN | aggrecan | 0.037 | ||
| AMOTL2 | angiomotin like 2 | 0.037 | ||
| LDHB | lactate dehydrogenase B | 0.037 | ||
| NGF | nerve growth factor (beta polypeptide) | 0.037 | ||
| PPP2CB | protein phosphatase 2, catalytic subunit, beta isozyme | 0.037 | ||
| UTY | ubiquitously transcribed tetratricopeptide repeat gene, Y-linked | 0.037 | ||
| MAP3K1 | mitogen-activated protein kinase kinase kinase 1 | 0.037 | ||
| NR2F2 | nuclear receptor subfamily 2, group F, member 2 | 0.037 | ||
| SP100 | SP100 nuclear antigen | 0.036 | ||
| AZI2 | 5-azacytidine induced 2 | 0.036 | ||
| EIF3G | eukaryotic translation initiation factor 3, subunit G | 0.036 | ||
| CHST3 | carbohydrate (chondroitin 6) sulfotransferase 3 | 0.036 | ||
| USP18 | ubiquitin specific peptidase 18 | 0.036 | ||
| SNX33 | sorting nexin 33 | 0.035 | ||
| RRM2B | ribonucleotide reductase M2 B (TP53 inducible) | 0.035 | ||
| TBX2 | T-box 2 | 0.035 | ||
| CAV2 | caveolin 2 | 0.035 | ||
| ADAMTS1 | ADAM metallopeptidase with thrombospondin type 1 motif, 1 | 0.035 | ||
| FOXF2 | forkhead box F2 | 0.035 | ||
| PPP3R1 | protein phosphatase 3, regulatory subunit B, alpha | 0.035 | ||
| KIAA1967 | KIAA1967 | 0.035 | ||
| HRK | harakiri, BCL2 interacting protein (contains only BH3 domain) | 0.034 | ||
| IL18 | interleukin 18 (interferon-gamma-inducing factor) | 0.034 | ||
| PTEN | phosphatase and tensin homolog | 0.034 | ||
| COL5A2 | collagen, type V, alpha 2 | 0.034 | ||
| GTF2I | general transcription factor IIi | 0.034 | ||
| GOT2 | glutamic-oxaloacetic transaminase 2, mitochondrial (aspartate aminotransferase 2) | 0.034 | ||
| KDM5D | lysine (K)-specific demethylase 5D | 0.033 | ||
| SRGN | serglycin | 0.033 | ||
| PPP2R1B | protein phosphatase 2, regulatory subunit A, beta | 0.033 | ||
| HMGA2 | high mobility group AT-hook 2 | 0.033 | ||
| WT1 | Wilms tumor 1 | 0.033 | ||
| GRB7 | growth factor receptor-bound protein 7 | 0.033 | ||
| GDF9 | growth differentiation factor 9 | 0.033 | ||
| FIS1 | fission 1 (mitochondrial outer membrane) homolog (S. cerevisiae) | 0.033 | ||
| AXIN1 | axin 1 | 0.033 | ||
| MCRS1 | microspherule protein 1 | 0.033 | ||
| SIM2 | single-minded homolog 2 (Drosophila) | 0.033 | ||
| SOX18 | SRY (sex determining region Y)-box 18 | 0.032 | Human | |
| EFNB3 | ephrin-B3 | 0.032 | ||
| CSNK1A1 | casein kinase 1, alpha 1 | 0.032 | ||
| NPY2R | neuropeptide Y receptor Y2 | 0.032 | ||
| FBXO32 | F-box protein 32 | 0.032 | ||
| CREB3 | cAMP responsive element binding protein 3 | 0.032 | ||
| FOXC2 | forkhead box C2 (MFH-1, mesenchyme forkhead 1) | 0.032 | Human | |
| FBXW7 | F-box and WD repeat domain containing 7 | 0.032 | ||
| COL2A1 | collagen, type II, alpha 1 | 0.032 | ||
| SLC25A3 | solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 3 | 0.032 | ||
| HMGN2 | high mobility group nucleosomal binding domain 2 | 0.032 | ||
| CDKN1B | cyclin-dependent kinase inhibitor 1B (p27, Kip1) | 0.032 | ||
| YES1 | v-yes-1 Yamaguchi sarcoma viral oncogene homolog 1 | 0.032 | Human | |
| CCT8 | chaperonin containing TCP1, subunit 8 (theta) | 0.031 | ||
| RGS2 | regulator of G-protein signaling 2, 24kDa | 0.031 | ||
| CYorf15A | chromosome Y open reading frame 15A | 0.031 | ||
| ITCH | itchy E3 ubiquitin protein ligase homolog (mouse) | 0.031 | ||
| NKX3-1 | NK3 homeobox 1 | 0.031 | ||
| HBEGF | heparin-binding EGF-like growth factor | 0.031 | ||
| FKBP8 | FK506 binding protein 8, 38kDa | 0.031 | ||
| NLRP3 | NLR family, pyrin domain containing 3 | 0.031 | ||
| EDN1 | endothelin 1 | 0.031 | ||
| TEX10 | testis expressed 10 | 0.031 | ||
| SOX11 | SRY (sex determining region Y)-box 11 | 0.031 | Human | |
| TUBB2B | tubulin, beta 2B | 0.031 | ||
| CARD10 | caspase recruitment domain family, member 10 | 0.031 | ||
| HSPH1 | heat shock 105kDa/110kDa protein 1 | 0.031 | ||
| PI3 | peptidase inhibitor 3, skin-derived | 0.030 | ||
| RPS27L | ribosomal protein S27-like | 0.030 | ||
| CREBL2 | cAMP responsive element binding protein-like 2 | 0.030 | ||
| HOXD1 | homeobox D1 | 0.030 | ||
| SOX1 | SRY (sex determining region Y)-box 1 | 0.030 | Human | |
| NDUFS2 | NADH dehydrogenase (ubiquinone) Fe-S protein 2, 49kDa (NADH-coenzyme Q reductase) | 0.030 | ||
| ZFP36 | zinc finger protein 36, C3H type, homolog (mouse) | 0.030 | ||
| PXDN | peroxidasin homolog (Drosophila) | 0.030 | ||
| MAPT | microtubule-associated protein tau | 0.030 | ||
| MAPK14 | mitogen-activated protein kinase 14 | 0.030 | ||
| PDCD6 | programmed cell death 6 | 0.030 | ||
| FZD1 | frizzled homolog 1 (Drosophila) | 0.030 | ||
| HAX1 | HCLS1 associated protein X-1 | 0.030 | ||
| PITX2 | paired-like homeodomain 2 | 0.030 | ||
| HSPA6 | heat shock 70kDa protein 6 (HSP70B') | 0.030 | ||
| CRIM1 | cysteine rich transmembrane BMP regulator 1 (chordin-like) | 0.030 | ||
| KLF2 | Kruppel-like factor 2 (lung) | 0.030 | ||
| EIF4G1 | eukaryotic translation initiation factor 4 gamma, 1 | 0.030 | ||
| FOSB | FBJ murine osteosarcoma viral oncogene homolog B | 0.029 | ||
| MYOD1 | myogenic differentiation 1 | 0.029 | ||
| DDAH2 | dimethylarginine dimethylaminohydrolase 2 | 0.029 | ||
| SPTBN1 | spectrin, beta, non-erythrocytic 1 | 0.029 | ||
| SOX9 | SRY (sex determining region Y)-box 9 | 0.029 | Human | |
| PPID | peptidylprolyl isomerase D | 0.029 | ||
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.029 | Human | |
| ETS2 | v-ets erythroblastosis virus E26 oncogene homolog 2 (avian) | 0.029 | ||
| HOXC8 | homeobox C8 | 0.029 | ||
| MET | met proto-oncogene (hepatocyte growth factor receptor) | 0.029 | ||
| SMARCC2 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 2 | 0.029 | ||
| SNIP1 | Smad nuclear interacting protein 1 | 0.029 | ||
| RAMP2 | receptor (G protein-coupled) activity modifying protein 2 | 0.029 | ||
| SOX4 | SRY (sex determining region Y)-box 4 | 0.029 | Human | |
| SOX7 | SRY (sex determining region Y)-box 7 | 0.029 | ||
| KLF6 | Kruppel-like factor 6 | 0.029 | ||
| LRRK2 | leucine-rich repeat kinase 2 | 0.029 | ||
| MATR3 | matrin 3 | 0.028 | ||
| SLC4A1 | solute carrier family 4, anion exchanger, member 1 (erythrocyte membrane protein band 3, Diego blood group) | 0.028 | ||
| PIGA | phosphatidylinositol glycan anchor biosynthesis, class A | 0.028 | ||
| DAP3 | death associated protein 3 | 0.028 | ||
| USP9Y | ubiquitin specific peptidase 9, Y-linked | 0.028 | ||
| TFAP2C | transcription factor AP-2 gamma (activating enhancer binding protein 2 gamma) | 0.028 | ||
| MSX1 | msh homeobox 1 | 0.028 | ||
| AHNAK | AHNAK nucleoprotein | 0.028 | ||
| TRMT2A | TRM2 tRNA methyltransferase 2 homolog A (S. cerevisiae) | 0.028 | ||
| RIPK3 | receptor-interacting serine-threonine kinase 3 | 0.028 | ||
| USP2 | ubiquitin specific peptidase 2 | 0.028 | ||
| GFAP | glial fibrillary acidic protein | 0.028 | ||
| CARD6 | caspase recruitment domain family, member 6 | 0.028 | ||
| FOXG1 | forkhead box G1 | 0.027 | Human | |
| ONECUT1 | one cut homeobox 1 | 0.027 | ||
| JAG1 | jagged 1 | 0.027 | ||
| PPP2R5A | protein phosphatase 2, regulatory subunit B', alpha | 0.027 | ||
| LAMC2 | laminin, gamma 2 | 0.027 | ||
| FBXO33 | F-box protein 33 | 0.027 | ||
| IL1RN | interleukin 1 receptor antagonist | 0.027 | ||
| PDHA1 | pyruvate dehydrogenase (lipoamide) alpha 1 | 0.027 | ||
| EPHA2 | EPH receptor A2 | 0.027 | ||
| ASB6 | ankyrin repeat and SOCS box containing 6 | 0.027 | ||
| TRAF4 | TNF receptor-associated factor 4 | 0.027 | ||
| IL6ST | interleukin 6 signal transducer (gp130, oncostatin M receptor) | 0.027 | ||
| LY6D | lymphocyte antigen 6 complex, locus D | 0.027 | ||
| EMP1 | epithelial membrane protein 1 | 0.026 | ||
| IER2 | immediate early response 2 | 0.026 | ||
| RBMX | RNA binding motif protein, X-linked | 0.026 | ||
| ID4 | inhibitor of DNA binding 4, dominant negative helix-loop-helix protein | 0.026 | ||
| PAPPA | pregnancy-associated plasma protein A, pappalysin 1 | 0.026 | ||
| IRF3 | interferon regulatory factor 3 | 0.026 | ||
| SDHC | succinate dehydrogenase complex, subunit C, integral membrane protein, 15kDa | 0.026 | ||
| FKBP4 | FK506 binding protein 4, 59kDa | 0.026 | ||
| ACYP1 | acylphosphatase 1, erythrocyte (common) type | 0.026 | ||
| TP63 | tumor protein p63 | 0.026 | ||
| S100A10 | S100 calcium binding protein A10 | 0.026 | Human | |
| CCND2 | cyclin D2 | 0.026 | ||
| LRP6 | low density lipoprotein receptor-related protein 6 | 0.026 | ||
| MED31 | mediator complex subunit 31 | 0.026 | ||
| PRKCDBP | protein kinase C, delta binding protein | 0.026 | ||
| SOX8 | SRY (sex determining region Y)-box 8 | 0.026 | Human | |
| HOXD13 | homeobox D13 | 0.026 | ||
| FOXC1 | forkhead box C1 | 0.026 | Human | |
| CSTB | cystatin B (stefin B) | 0.026 | ||
| DDB2 | damage-specific DNA binding protein 2, 48kDa | 0.026 | ||
| SPG20 | spastic paraplegia 20 (Troyer syndrome) | 0.025 | ||
| FGFR3 | fibroblast growth factor receptor 3 | 0.025 | ||
| MIPEP | mitochondrial intermediate peptidase | 0.025 | ||
| EEF1A1 | eukaryotic translation elongation factor 1 alpha 1 | 0.025 | ||
| HSPA1B | heat shock 70kDa protein 1B | 0.025 | ||
| HSPA1A | heat shock 70kDa protein 1A | 0.025 | ||
| EN2 | engrailed homeobox 2 | 0.025 | ||
| RPS24 | ribosomal protein S24 | 0.025 | ||
| HEYL | hairy/enhancer-of-split related with YRPW motif-like | 0.025 | ||
| GBP1 | guanylate binding protein 1, interferon-inducible | 0.025 | ||
| SIRT1 | sirtuin 1 | 0.025 | ||
| MCAM | melanoma cell adhesion molecule | 0.025 | ||
| RHOJ | ras homolog gene family, member J | 0.025 | ||
| HMX1 | H6 family homeobox 1 | 0.025 | ||
| PDE4DIP | phosphodiesterase 4D interacting protein | 0.025 | ||
| BMP7 | bone morphogenetic protein 7 | 0.025 | Human | |
| PPBP | pro-platelet basic protein (chemokine (C-X-C motif) ligand 7) | 0.024 | ||
| CXCL1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | 0.024 | ||
| ZFX | zinc finger protein, X-linked | 0.024 | ||
| ROMO1 | reactive oxygen species modulator 1 | 0.024 | ||
| IRF1 | interferon regulatory factor 1 | 0.024 | ||
| TNFAIP2 | tumor necrosis factor, alpha-induced protein 2 | 0.024 | ||
| FERMT2 | fermitin family member 2 | 0.024 | ||
| CHCHD3 | coiled-coil-helix-coiled-coil-helix domain containing 3 | 0.024 | ||
| NR0B2 | nuclear receptor subfamily 0, group B, member 2 | 0.024 | ||
| BRCA2 | breast cancer 2, early onset | 0.024 | ||
| HIC1 | hypermethylated in cancer 1 | 0.024 | ||
| MRPL34 | mitochondrial ribosomal protein L34 | 0.024 | ||
| C17orf37 | chromosome 17 open reading frame 37 | 0.024 | ||
| RPL5 | ribosomal protein L5 | 0.024 | ||
| EMR1 | egf-like module containing, mucin-like, hormone receptor-like 1 | 0.024 | ||
| ANP32A | acidic (leucine-rich) nuclear phosphoprotein 32 family, member A | 0.024 | Human | |
| KDM1A | lysine (K)-specific demethylase 1A | 0.024 | ||
| NDUFB10 | NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 10, 22kDa | 0.024 | ||
| APOO | apolipoprotein O | 0.024 | ||
| GNA15 | guanine nucleotide binding protein (G protein), alpha 15 (Gq class) | 0.024 | ||
| ARHGAP29 | Rho GTPase activating protein 29 | 0.024 | ||
| PMEPA1 | prostate transmembrane protein, androgen induced 1 | 0.023 | ||
| DAPP1 | dual adaptor of phosphotyrosine and 3-phosphoinositides | 0.023 | ||
| DUT | deoxyuridine triphosphatase | 0.023 | ||
| MAP3K3 | mitogen-activated protein kinase kinase kinase 3 | 0.023 | ||
| ASB7 | ankyrin repeat and SOCS box containing 7 | 0.023 | ||
| CYC1 | cytochrome c-1 | 0.023 | ||
| ERH | enhancer of rudimentary homolog (Drosophila) | 0.023 | ||
| LCN2 | lipocalin 2 | 0.023 | ||
| ZIC3 | Zic family member 3 (odd-paired homolog, Drosophila) | 0.023 | ||
| CALD1 | caldesmon 1 | 0.023 | ||
| ASH2L | ash2 (absent, small, or homeotic)-like (Drosophila) | 0.023 | ||
| DHFR | dihydrofolate reductase | 0.023 | ||
| MAP3K14 | mitogen-activated protein kinase kinase kinase 14 | 0.023 | ||
| TG | thyroglobulin | 0.023 | ||
| JAK1 | Janus kinase 1 | 0.022 | ||
| KRAS | v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog | 0.022 | ||
| GJA4 | gap junction protein, alpha 4, 37kDa | 0.022 | ||
| POU3F3 | POU class 3 homeobox 3 | 0.022 | ||
| TCP1 | t-complex 1 | 0.022 | ||
| NOL3 | nucleolar protein 3 (apoptosis repressor with CARD domain) | 0.022 | ||
| NDUFA8 | NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 8, 19kDa | 0.022 | ||
| RSL24D1 | ribosomal L24 domain containing 1 | 0.022 | ||
| SMPD1 | sphingomyelin phosphodiesterase 1, acid lysosomal | 0.022 | ||
| EIF3B | eukaryotic translation initiation factor 3, subunit B | 0.022 | ||
| TRAF6 | TNF receptor-associated factor 6 | 0.022 | ||
| FPR2 | formyl peptide receptor 2 | 0.022 | ||
| HIST2H3C | histone cluster 2, H3c | 0.022 | ||
| SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 0.022 | ||
| BARX1 | BARX homeobox 1 | 0.022 | ||
| SOX17 | SRY (sex determining region Y)-box 17 | 0.022 | Human | |
| PIK3R3 | phosphoinositide-3-kinase, regulatory subunit 3 (gamma) | 0.022 | ||
| RANGAP1 | Ran GTPase activating protein 1 | 0.022 | ||
| TCF7L1 | transcription factor 7-like 1 (T-cell specific, HMG-box) | 0.022 | ||
| SH2B1 | SH2B adaptor protein 1 | 0.022 | ||
| SH3BP5 | SH3-domain binding protein 5 (BTK-associated) | 0.022 | ||
| MXD1 | MAX dimerization protein 1 | 0.022 | ||
| GNAQ | guanine nucleotide binding protein (G protein), q polypeptide | 0.021 | ||
| IRF9 | interferon regulatory factor 9 | 0.021 | ||
| ANP32E | acidic (leucine-rich) nuclear phosphoprotein 32 family, member E | 0.021 | Human | |
| FZD7 | frizzled homolog 7 (Drosophila) | 0.021 | ||
| GPR109B | G protein-coupled receptor 109B | 0.021 | ||
| UBE2Q1 | ubiquitin-conjugating enzyme E2Q family member 1 | 0.021 | ||
| STK17B | serine/threonine kinase 17b | 0.021 | ||
| MTMR10 | myotubularin related protein 10 | 0.021 | ||
| AIM2 | absent in melanoma 2 | 0.021 | ||
| BEST2 | bestrophin 2 | 0.021 | ||
| PPM1D | protein phosphatase, Mg2+/Mn2+ dependent, 1D | 0.021 | ||
| RFWD2 | ring finger and WD repeat domain 2 | 0.021 | ||
| KYNU | kynureninase | 0.021 | ||
| F7 | coagulation factor VII (serum prothrombin conversion accelerator) | 0.021 | ||
| KAZALD1 | Kazal-type serine peptidase inhibitor domain 1 | 0.021 | ||
| CCNB2 | cyclin B2 | 0.021 | ||
| MPZL2 | myelin protein zero-like 2 | 0.021 | ||
| OSTF1 | osteoclast stimulating factor 1 | 0.021 | ||
| LMNB1 | lamin B1 | 0.021 | ||
| ATF3 | activating transcription factor 3 | 0.021 | ||
| HOXD12 | homeobox D12 | 0.021 | ||
| MT1A | metallothionein 1A | 0.021 | ||
| S100A13 | S100 calcium binding protein A13 | 0.021 | ||
| TCF3 | transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47) | 0.021 | ||
| FRZB | frizzled-related protein | 0.021 | ||
| GRSF1 | G-rich RNA sequence binding factor 1 | 0.021 | ||
| PAX1 | paired box 1 | 0.021 | ||
| FZD10 | frizzled homolog 10 (Drosophila) | 0.021 | ||
| VENTX | VENT homeobox homolog (Xenopus laevis) | 0.021 | ||
| LTBP2 | latent transforming growth factor beta binding protein 2 | 0.021 | ||
| CSF3R | colony stimulating factor 3 receptor (granulocyte) | 0.021 | ||
| SLPI | secretory leukocyte peptidase inhibitor | 0.021 | ||
| GSC | goosecoid homeobox | 0.021 | ||
| IL18RAP | interleukin 18 receptor accessory protein | 0.021 | ||
| ATP5C1 | ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1 | 0.020 | ||
| ARHGAP19 | Rho GTPase activating protein 19 | 0.020 | ||
| TNIP1 | TNFAIP3 interacting protein 1 | 0.020 | ||
| NR4A3 | nuclear receptor subfamily 4, group A, member 3 | 0.020 | ||
| OLIG2 | oligodendrocyte lineage transcription factor 2 | 0.020 | ||
| DIO2 | deiodinase, iodothyronine, type II | 0.020 | ||
| SOX10 | SRY (sex determining region Y)-box 10 | 0.020 | Human | |
| SUB1 | SUB1 homolog (S. cerevisiae) | 0.020 | ||
| C19orf56 | chromosome 19 open reading frame 56 | 0.020 | ||
| VEGFC | vascular endothelial growth factor C | 0.020 | ||
| CASP5 | caspase 5, apoptosis-related cysteine peptidase | 0.020 | Fly | |
| DLC1 | deleted in liver cancer 1 | 0.020 | ||
| CCDC51 | coiled-coil domain containing 51 | 0.020 | ||
| MAP3K5 | mitogen-activated protein kinase kinase kinase 5 | 0.020 | ||
| AHR | aryl hydrocarbon receptor | 0.020 | ||
| FXYD3 | FXYD domain containing ion transport regulator 3 | 0.020 | ||
| DAB2 | disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila) | 0.020 | ||
| DNMT3B | DNA (cytosine-5-)-methyltransferase 3 beta | 0.020 | ||
| NLRP1 | NLR family, pyrin domain containing 1 | 0.020 | ||
| F2R | coagulation factor II (thrombin) receptor | 0.020 | ||
| PRRX2 | paired related homeobox 2 | 0.020 | ||
| GJA1 | gap junction protein, alpha 1, 43kDa | 0.020 | ||
| ARHGAP9 | Rho GTPase activating protein 9 | 0.020 | ||
| SLC6A3 | solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 | 0.020 | ||
| TNS3 | tensin 3 | 0.020 | ||
| EREG | epiregulin | 0.020 | ||
| HOXD9 | homeobox D9 | 0.020 | ||
| LHX1 | LIM homeobox 1 | 0.020 | ||
| FOXA1 | forkhead box A1 | 0.020 | Human | |
| YWHAQ | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta polypeptide | 0.020 | ||
| ZFY | zinc finger protein, Y-linked | 0.020 | ||
| SIX2 | SIX homeobox 2 | 0.020 | ||
| SAT1 | spermidine/spermine N1-acetyltransferase 1 | 0.020 | ||
| NR2E1 | nuclear receptor subfamily 2, group E, member 1 | 0.020 | ||
| MAFIP | MAFF interacting protein | 0.020 | ||
| GDNF | glial cell derived neurotrophic factor | 0.020 | ||
| SRI | sorcin | 0.020 | ||
| TFAP2A | transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) | 0.020 | ||
| ZNF512B | zinc finger protein 512B | 0.020 | ||
| IL11 | interleukin 11 | 0.019 | ||
| SFRP1 | secreted frizzled-related protein 1 | 0.019 | ||
| NFATC4 | nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4 | 0.019 | ||
| EGR2 | early growth response 2 | 0.019 | ||
| LAMP2 | lysosomal-associated membrane protein 2 | 0.019 | ||
| MLL2 | myeloid/lymphoid or mixed-lineage leukemia 2 | 0.019 | ||
| ALOX5 | arachidonate 5-lipoxygenase | 0.019 | ||
| AQP9 | aquaporin 9 | 0.019 | ||
| CDK11B | cyclin-dependent kinase 11B | 0.019 | ||
| PNPO | pyridoxamine 5'-phosphate oxidase | 0.019 | ||
| RNF10 | ring finger protein 10 | 0.019 | ||
| CA6 | carbonic anhydrase VI | 0.019 | ||
| OTX2 | orthodenticle homeobox 2 | 0.019 | ||
| NPPC | natriuretic peptide C | 0.019 | ||
| CRABP1 | cellular retinoic acid binding protein 1 | 0.019 | ||
| SKI | v-ski sarcoma viral oncogene homolog (avian) | 0.019 | ||
| PF4 | platelet factor 4 | 0.019 | ||
| MECR | mitochondrial trans-2-enoyl-CoA reductase | 0.019 | ||
| FILIP1L | filamin A interacting protein 1-like | 0.019 | ||
| CLDN18 | claudin 18 | 0.019 | ||
| UBA2 | ubiquitin-like modifier activating enzyme 2 | 0.019 | ||
| CDK5RAP2 | CDK5 regulatory subunit associated protein 2 | 0.019 | ||
| CD44 | CD44 molecule (Indian blood group) | 0.019 | ||
| TM4SF1 | transmembrane 4 L six family member 1 | 0.019 | ||
| CNTN2 | contactin 2 (axonal) | 0.019 | ||
| IGF1R | insulin-like growth factor 1 receptor | 0.019 | ||
| BAG2 | BCL2-associated athanogene 2 | 0.019 | ||
| MYL9 | myosin, light chain 9, regulatory | 0.019 | ||
| SHARPIN | SHANK-associated RH domain interactor | 0.019 | ||
| BHLHE22 | basic helix-loop-helix family, member e22 | 0.019 | ||
| THBD | thrombomodulin | 0.019 | ||
| OTP | orthopedia homeobox | 0.019 | ||
| LAMTOR2 | late endosomal/lysosomal adaptor, MAPK and MTOR activator 2 | 0.019 | ||
| GLRX | glutaredoxin (thioltransferase) | 0.019 | ||
| GSN | gelsolin | 0.019 | ||
| GDF6 | growth differentiation factor 6 | 0.019 | Human | |
| KLK6 | kallikrein-related peptidase 6 | 0.019 | ||
| PAX6 | paired box 6 | 0.019 | ||
| PGK1 | phosphoglycerate kinase 1 | 0.019 | ||
| SPHK1 | sphingosine kinase 1 | 0.019 | ||
| SMURF1 | SMAD specific E3 ubiquitin protein ligase 1 | 0.018 | ||
| SCRT1 | scratch homolog 1, zinc finger protein (Drosophila) | 0.018 | ||
| TEC | tec protein tyrosine kinase | 0.018 | ||
| CD1D | CD1d molecule | 0.018 | ||
| STAT2 | signal transducer and activator of transcription 2, 113kDa | 0.018 | ||
| MYST1 | MYST histone acetyltransferase 1 | 0.018 | ||
| CLEC14A | C-type lectin domain family 14, member A | 0.018 | ||
| APLP1 | amyloid beta (A4) precursor-like protein 1 | 0.018 | ||
| PTAFR | platelet-activating factor receptor | 0.018 | ||
| FOXQ1 | forkhead box Q1 | 0.018 | Human | |
| USP15 | ubiquitin specific peptidase 15 | 0.018 | ||
| SLC2A1 | solute carrier family 2 (facilitated glucose transporter), member 1 | 0.018 | ||
| BRCA1 | breast cancer 1, early onset | 0.018 | ||
| FPR1 | formyl peptide receptor 1 | 0.018 | ||
| OBFC2A | oligonucleotide/oligosaccharide-binding fold containing 2A | 0.018 | ||
| SALL3 | sal-like 3 (Drosophila) | 0.018 | ||
| OPRD1 | opioid receptor, delta 1 | 0.018 | ||
| PROCR | protein C receptor, endothelial | 0.018 | ||
| RUNX2 | runt-related transcription factor 2 | 0.018 | ||
| B2M | beta-2-microglobulin | 0.018 | ||
| FGF18 | fibroblast growth factor 18 | 0.018 | ||
| EIF3I | eukaryotic translation initiation factor 3, subunit I | 0.018 | ||
| CCNE2 | cyclin E2 | 0.018 | ||
| FDXR | ferredoxin reductase | 0.018 | ||
| MECOM | MDS1 and EVI1 complex locus | 0.018 | ||
| FAM107A | family with sequence similarity 107, member A | 0.018 | ||
| MYL6 | myosin, light chain 6, alkali, smooth muscle and non-muscle | 0.018 | ||
| ENDOG | endonuclease G | 0.018 | ||
| IVL | involucrin | 0.018 | ||
| PCDH8 | protocadherin 8 | 0.018 | ||
| TAX1BP3 | Tax1 (human T-cell leukemia virus type I) binding protein 3 | 0.018 | ||
| NEDD9 | neural precursor cell expressed, developmentally down-regulated 9 | 0.018 | ||
| CCNA2 | cyclin A2 | 0.018 | ||
| SOX5 | SRY (sex determining region Y)-box 5 | 0.018 | ||
| NKX3-2 | NK3 homeobox 2 | 0.018 | ||
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.018 | ||
| SMARCE1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1 | 0.018 | ||
| RPS6KA6 | ribosomal protein S6 kinase, 90kDa, polypeptide 6 | 0.018 | ||
| LILRA1 | leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 1 | 0.018 | ||
| CYP26A1 | cytochrome P450, family 26, subfamily A, polypeptide 1 | 0.018 | ||
| WNT5A | wingless-type MMTV integration site family, member 5A | 0.018 | ||
| CFP | complement factor properdin | 0.018 | ||
| ARF5 | ADP-ribosylation factor 5 | 0.018 |